Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial

BACKGROUND: Elderly patients have been often excluded from or underrepresented in the study populations of combination chemotherapy trials. The primary end point of this study was to determine the response rate and the toxicity of the weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) regim...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Santini, D, Graziano, F, Catalano, V, Di Seri, M, Testa, E, Baldelli, AM, Giordani, P, La Cesa, A, Spalletta, B, Vincenzi, B, Russo, A, Caraglia, M, Virzi, V, Cascinu, S, Tonini, G
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2006
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1475875/
https://ncbi.nlm.nih.gov/pubmed/16686939
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-6-125
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados